Prospective, Randomised, Double-blind, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of 25 mg Natural Progesterone Administered Subcutaneously in Restoring the Normal Luteal Phase in Women With Previous Diagnosis of Luteal Phase Deficiency

Trial Profile

Prospective, Randomised, Double-blind, Placebo Controlled, Phase III Clinical Study Assessing the Efficacy of 25 mg Natural Progesterone Administered Subcutaneously in Restoring the Normal Luteal Phase in Women With Previous Diagnosis of Luteal Phase Deficiency

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 08 Dec 2017

At a glance

  • Drugs Progesterone (Primary)
  • Indications Female infertility
  • Focus Registrational; Therapeutic Use
  • Sponsors IBSA
  • Most Recent Events

    • 05 Dec 2017 Planned initiation date changed from 1 Sep 2017 to 3 May 2017.
    • 05 Dec 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 07 Jul 2017 Planned initiation date changed from 1 Mar 2017 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top